Los Angeles Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-42,049
| Closed | -$624K | – | 1531 |
|
|
2021
Q3 | $624K | Sell |
42,049
-2,210
| -5% | -$32.8K | ﹤0.01% | 954 |
|
|
2021
Q2 | $884K | Buy |
44,259
+16,506
| +59% | +$330K | ﹤0.01% | 909 |
|
|
2021
Q1 | $641K | Sell |
27,753
-12,264
| -31% | -$283K | ﹤0.01% | 1100 |
|
|
2020
Q4 | $988K | Buy |
40,017
+24,287
| +154% | +$600K | ﹤0.01% | 951 |
|
|
2020
Q3 | $652K | Sell |
15,730
-4,989
| -24% | -$207K | ﹤0.01% | 985 |
|
|
2020
Q2 | $993K | Buy |
20,719
+5,739
| +38% | +$275K | ﹤0.01% | 855 |
|
|
2020
Q1 | $943K | Hold |
14,980
| – | – | 0.01% | 723 |
|
|
2019
Q4 | $1.86M | Buy |
14,980
+7,580
| +102% | +$939K | 0.01% | 667 |
|
|
2019
Q3 | $491K | Buy |
7,400
+4,353
| +143% | +$289K | ﹤0.01% | 992 |
|
|
2019
Q2 | $242K | Sell |
3,047
-20
| -0.7% | -$1.59K | ﹤0.01% | 1245 |
|
|
2019
Q1 | $343K | Buy |
+3,067
| New | +$343K | ﹤0.01% | 1170 |
|
|
2014
Q3 | – | Sell |
-2,877
| Closed | -$681K | – | 1182 |
|
|
2014
Q2 | $681K | Buy |
+2,877
| New | +$681K | 0.01% | 789 |
|